Last 17 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has compressed 69.4% YoY to 3.0x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 | Q4 '18 | Q3 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 5.94 | — | 6.57 | 11.85 | 4.97 | 24.18 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.22 | 0.30 | 0.29 | 0.32 | 0.35 | 0.44 | — | — | — | — | — | — | — |
| — | -31.9% | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.82 | 1.15 | 1.17 | 1.24 | 1.49 | 1.82 | — | — | — | — | — | — | — |
| — | -37.1% | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 10.51 | 5.03 | 6.76 | — | 14.80 | 12.98 | — | — | — | — | — | — | — |
| — | -61.2% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 5.55 | 3.01 | 5.17 | 8.99 | 2.66 | 9.84 | — | — | — | — | — | — | — |
| — | -69.4% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 7.56 | 53.74 | 6.68 | 10.51 | 6.33 | 14.71 | — | — | — | — | — | — | — |
| — | +265.4% | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Ardent Health Partners, LLC's operating margin was 16.1% in Q3 2025, up 7.8 pp QoQ and up 11.3 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 12.5% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 30.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 | Q4 '18 | Q3 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.7% | 57.1% | 83.6% | 82.7% | 59.3% | 82.6% | 82.4% | 82.1% | 55.6% | 97.4% | 100.0% | 100.0% | 51.5% |
| — | -30.9% | +1.4% | +0.8% | +6.7% | -15.1% | -17.6% | -17.9% | +7.8% | +88.9% | +271.6% | +86.9% | -5.3% | |
| Operating Margin | 6.8% | 16.1% | 8.3% | 4.5% | 21.0% | 4.9% | -10.7% | 5.3% | 12.8% | 4.1% | 4.8% | 4.8% | 12.8% |
| — | +232.3% | +178.0% | -15.0% | +64.2% | +18.1% | -322.9% | +10.1% | -0.3% | -67.9% | +373.9% | -67.2% | -40.4% | |
| Net Margin | 3.5% | -1.5% | 4.4% | 2.8% | 7.1% | 1.8% | 2.9% | 1.9% | -0.3% | 0.3% | -6.6% | 0.5% | -3.8% |
| — | -182.0% | +52.5% | +47.1% | +2404.6% | +477.1% | +143.8% | +272.9% | +92.0% | +108.2% | +20.3% | -5.3% | -313.2% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 | Q4 '18 | Q3 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.2% | -1.4% | 4.5% | 2.7% | 7.9% | 2.1% | 3.8% | 2.5% | -0.4% | — | -9.6% | 0.7% | -4.9% |
| — | -169.4% | +21.0% | +8.9% | +2146.2% | — | +139.0% | +253.2% | +92.1% | — | +73.9% | +10.6% | -506.1% | |
| ROA | 4.2% | -0.5% | 1.5% | 0.8% | 2.3% | 0.6% | 0.9% | 0.6% | -0.1% | — | -2.6% | 0.2% | -1.3% |
| — | -182.4% | +57.9% | +50.3% | +2976.2% | — | +135.6% | +186.0% | +94.0% | — | +56.9% | — | -402.2% | |
| ROIC | 9.7% | 5.7% | 3.1% | 1.5% | 8.0% | 1.7% | -3.8% | 1.9% | 6.3% | 6.8% | 2.0% | 2.0% | 4.8% |
| — | +233.3% | +180.0% | -17.8% | +27.8% | -74.6% | -290.9% | -5.2% | +30.3% | +15.4% | +173.4% | -76.0% | -15.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Ardent Health Partners, LLC's Debt/EBITDA ratio is 7.8x, down from 12.8x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 8.9% YoY to 2.08x, strengthening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q1 '23 | Q4 '18 | Q3 '18 | Q2 '18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.50 | 1.39 | 1.38 | 1.45 | 1.50 | 1.62 | 1.93 | 2.10 | 2.21 | — | 1.77 | 1.61 | 1.66 |
| — | -14.1% | -28.8% | -30.8% | -32.3% | — | +9.2% | +30.4% | +33.5% | — | -28.9% | — | +45.1% | |
| Debt / EBITDA | 4.13 | 7.75 | 12.84 | 22.04 | 6.09 | 21.02 | — | 21.09 | 11.53 | — | 14.70 | 14.23 | 7.97 |
| — | -63.1% | — | +4.5% | -47.2% | — | — | +48.2% | +44.6% | — | -96.2% | — | +19.0% | |
| Current Ratio | 1.94 | 2.08 | 2.13 | 2.12 | 1.94 | 1.91 | 1.65 | 1.79 | 1.63 | — | 1.38 | 1.55 | 1.55 |
| — | +8.9% | +29.0% | +18.8% | +19.1% | — | +20.0% | +15.2% | +5.0% | — | -5.1% | — | -17.1% | |
| Quick Ratio | 1.82 | 1.95 | 2.00 | 1.98 | 1.82 | 1.78 | 1.54 | 1.66 | 1.52 | — | 1.24 | 1.38 | 1.38 |
| — | +9.1% | +29.9% | +19.2% | +19.4% | — | +23.8% | +20.4% | +10.2% | — | -3.4% | — | -19.8% | |
| Interest Coverage | 6.19 | 18.28 | 9.32 | 4.73 | 24.90 | 4.81 | -8.67 | 4.45 | 17.96 | 2.99 | 2.37 | 1.84 | 4.49 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 17 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonArdent Health Partners, LLC's current P/E is 5.9x. The average P/E over the last 3 quarters is 7.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Ardent Health Partners, LLC's current operating margin is 6.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Ardent Health Partners, LLC's business trajectory between earnings reports.